Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Boehringer Ingelheim
Farmers Insurance
Cantor Fitzgerald
Daiichi Sankyo

Generated: December 14, 2017

DrugPatentWatch Database Preview

Details for Patent: 8,178,563

« Back to Dashboard

Which drugs does patent 8,178,563 protect, and when does it expire?

Patent 8,178,563 protects ODOMZO and is included in one NDA.

This patent has fifty-three patent family members in forty-three countries.

Summary for Patent: 8,178,563

Title:Compounds and compositions as hedgehog pathway modulators
Abstract: The invention provides a method for modulating the activity of the hedgehog signaling pathway. In particular, the invention provides a method for inhibiting aberrant growth states resulting from phenotypes such as Ptc loss-of-function, hedgehog gain-of-function, smoothened gain-of-function or Gli gain-of-function, comprising contacting a cell with a sufficient amount of a compound of Formula I.
Inventor(s): Gao; Wenqi (San Diego, CA), Jiang; Jiqing (San Diego, CA), Wan; Yongqin (Irvine, CA), Cheng; Dai (San Diego, CA), Han; Dong (San Diego, CA), Wu; Xu (San Diego, CA), Pan; Shifeng (San Diego, CA)
Assignee: IRM LLC (Hamilton, BM)
Application Number:12/299,290
Patent Claim Types:
see list of patent claims
Compound; Use;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
Sun Pharma GlobalODOMZOsonidegib phosphateCAPSULE;ORAL205266-001Jul 24, 2015RXYesYes► Subscribe► Subscribe► SubscribeYTREATMENT OF BASAL CELL CARCINOMA
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 8,178,563

PCT Information
PCT FiledMay 04, 2007PCT Application Number:PCT/US2007/068292
PCT Publication Date:November 15, 2007PCT Publication Number: WO2007/131201

International Patent Family for Patent: 8,178,563

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Costa Rica10399► Subscribe
Cuba20080202► Subscribe
Cuba23760► Subscribe
Cyprus1114471► Subscribe
Denmark2021328► Subscribe
Eurasian Patent Organization200870504► Subscribe
Eurasian Patent Organization018302► Subscribe
EcuadorSP088860► Subscribe
European Patent Office2021328► SubscribeCA 2015 00057Denmark► Subscribe
European Patent Office2021328► SubscribePA2015051Lithuania► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Express Scripts
Cantor Fitzgerald
Boehringer Ingelheim
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: